JPH04291155A - Enzyme labeled antibody - Google Patents
Enzyme labeled antibodyInfo
- Publication number
- JPH04291155A JPH04291155A JP8065591A JP8065591A JPH04291155A JP H04291155 A JPH04291155 A JP H04291155A JP 8065591 A JP8065591 A JP 8065591A JP 8065591 A JP8065591 A JP 8065591A JP H04291155 A JPH04291155 A JP H04291155A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- antibody
- group
- antibodies
- labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 62
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 62
- 125000003396 thiol group Chemical group [H]S* 0.000 claims abstract description 22
- 229940126619 mouse monoclonal antibody Drugs 0.000 claims abstract description 16
- 230000001603 reducing effect Effects 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 abstract description 57
- 125000003277 amino group Chemical group 0.000 abstract description 14
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 12
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000008363 phosphate buffer Substances 0.000 abstract description 7
- 239000003638 chemical reducing agent Substances 0.000 abstract description 6
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 abstract description 6
- 102000057297 Pepsin A Human genes 0.000 abstract description 5
- 108090000284 Pepsin A Proteins 0.000 abstract description 5
- 229940111202 pepsin Drugs 0.000 abstract description 5
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical group O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 102000005936 beta-Galactosidase Human genes 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000003505 Myosin Human genes 0.000 description 2
- 108060008487 Myosin Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 2
- 229960003151 mercaptamine Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- VLARLSIGSPVYHX-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 6-(2,5-dioxopyrrol-1-yl)hexanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCN1C(=O)C=CC1=O VLARLSIGSPVYHX-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- DEENCNYPFDWDSA-UHFFFAOYSA-N 2-ethyl-1,3-benzothiazole-6-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2SC(CC)=NC2=C1 DEENCNYPFDWDSA-UHFFFAOYSA-N 0.000 description 1
- RLFPCLMBTQOMLI-UHFFFAOYSA-N 2-iodo-n-[2-[(2-iodoacetyl)amino]ethyl]acetamide Chemical compound ICC(=O)NCCNC(=O)CI RLFPCLMBTQOMLI-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000016349 Myosin Light Chains Human genes 0.000 description 1
- 108010067385 Myosin Light Chains Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、生命科学や医学の基礎
分野のほか臨床検査等で広く実施されている酵素免疫測
定法の主要構成試薬である酵素標識抗体に関するもので
ある。FIELD OF INDUSTRIAL APPLICATION The present invention relates to enzyme-labeled antibodies, which are the main constituent reagents of enzyme immunoassays, which are widely practiced in the basic fields of life science and medicine as well as in clinical tests.
【0002】0002
【従来の技術】従来利用されている酵素標識抗体は、抗
体のアミノ基を利用する方法または抗体を還元し、遊離
してくるスルフヒドリル基を利用して酵素と結合させる
方法によって調製されるものに大別される。[Prior Art] Enzyme-labeled antibodies that have been used conventionally are those prepared by a method that utilizes the amino group of the antibody or a method that reduces the antibody and binds it to an enzyme using the liberated sulfhydryl group. Broadly classified.
【0003】抗体のアミノ基を利用して酵素標識抗体を
得る方法には、分子内に二個の反応基を持つ二価性結合
試薬であるグルタルアルデヒドを用い抗体のアミノ基及
び酵素のアミノ基を結合させ、架橋するグルタルアルデ
ヒド法、西洋ワサビペルオキシダーゼを過ヨウ素酸を用
い酵素中の糖鎖を酸化開裂させてアルデヒド基を遊離さ
せ、このアルデヒド基と抗体のアミノ基を結合させる過
ヨウ素酸酸化法などが知られている。[0003] A method for obtaining an enzyme-labeled antibody using the amino group of an antibody uses glutaraldehyde, which is a bivalent binding reagent with two reactive groups in the molecule, to bind the amino group of the antibody and the amino group of the enzyme. glutaraldehyde method, in which horseradish peroxidase is combined with periodic acid to oxidize and cleave the sugar chain in the enzyme to liberate an aldehyde group, and periodate oxidation, in which this aldehyde group is combined with the amino group of the antibody. The law is known.
【0004】二価性結合試薬とは、分子内に二個の反応
基を持ち、蛋白のアミノ基、スルフヒドリル基等の官能
基と反応して、蛋白の分子内又は分子間架橋をする試薬
である。アミノ基間の架橋をするものにはグルタルアル
デヒド、1,5−difluoro−2,4−dini
trobenzen等があり、スルフヒドリル基間の架
橋をするものにはN,N’−o−phenylened
imaleimide、N,N’−ethylene−
bis−(iodoacetoamide)等がある。
またアミノ基とスルフヒドリル基を結合させるヘテロフ
ァンクショナルな二価性結合試薬としては、N−suc
cinimidyl−6−maleimidohexa
noate、N−succinimidyl−4−(N
−maleimidomethyl)−cyclohe
xane−1−carboxylate等がある。[0004] A divalent binding reagent is a reagent that has two reactive groups in its molecule and reacts with functional groups such as amino groups and sulfhydryl groups of proteins to form intramolecular or intermolecular crosslinks of proteins. be. Glutaraldehyde, 1,5-difluoro-2,4-dini
trobenzen, etc., and those that bridge between sulfhydryl groups include N,N'-o-phenylened.
imalimide, N, N'-ethylene-
bis-(iodoacetoamide) and the like. In addition, as a heterofunctional divalent binding reagent for binding an amino group and a sulfhydryl group,
cinimidyl-6-maleimidohexa
noate, N-succinimidyl-4-(N
-maleimidomethyl)-cyclohe
There are xane-1-carboxylate and the like.
【0005】しかし上述の方法は抗体上に存在する不特
定多数のアミノ基を利用するため、抗体の不特定の位置
に酵素が結合する。この結果、抗体の抗原結合部位に直
接酵素を結合することや抗原結合部位の近辺部位に結合
した酵素の立体障害等によって抗体活性が著しく低下す
ることが多い。また特にグルタルアルデヒド法において
は、酵素間や抗体間の結合も起こる為、得られる酵素標
識抗体は、分子量が一定せず、また低活性、高ブランク
値のものとなり、高感度酵素免疫測定には不適当なもの
であった。However, since the above-mentioned method utilizes an unspecified number of amino groups present on the antibody, the enzyme is bound to an unspecified position on the antibody. As a result, antibody activity is often significantly reduced due to direct binding of the enzyme to the antigen-binding site of the antibody or steric hindrance of the enzyme bound to the vicinity of the antigen-binding site. In addition, especially in the glutaraldehyde method, bonding between enzymes and antibodies also occurs, so the resulting enzyme-labeled antibodies have variable molecular weights, low activity, and high blank values, making them unsuitable for high-sensitivity enzyme immunoassays. It was inappropriate.
【0006】一方抗体のスルフヒドリル基を利用する方
法としては、ウサギ抗体をペプシンで消化しF(ab’
)2画分としたのち、還元剤を用い還元してスルフヒド
リル基の遊離したFab’画分を得、このスルフヒドリ
ル基と酵素のアミノ基またはスルフヒドリル基を二価性
結合試薬であるN−succinimidyl−4−(
N−maleimidomethyl)−cycloh
exane−1−carboxylate又はN,N’
−o−phenylenedimaleimideをそ
れぞれ用いて結合させ、酵素標識抗体を得る方法が知ら
れている。On the other hand, as a method using the sulfhydryl group of an antibody, a rabbit antibody is digested with pepsin and F(ab'
) After reducing the fractions with a reducing agent to obtain a Fab' fraction in which sulfhydryl groups are released, this sulfhydryl group and the amino group or sulfhydryl group of the enzyme are combined with a divalent binding reagent N-succinimidyl- 4-(
N-maleimidomethyl)-cycloh
exane-1-carboxylate or N,N'
A method is known in which an enzyme-labeled antibody is obtained by binding with -o-phenylene dimaleimide.
【0007】この方法で得られた酵素標識抗体は、抗体
の抗原結合部位と離れたヒンジ部位で酵素と結合するた
め、抗体活性の低下も少なく、比較的良質である。[0007] Since the enzyme-labeled antibody obtained by this method binds to the enzyme at a hinge site remote from the antigen-binding site of the antibody, there is little decrease in antibody activity and is of relatively high quality.
【0008】抗体に関しては、従来ウサギやヤギなどの
ポリクローナル抗体が多く用いられてきた。しかし近年
、特異性が高く、また一定品質のものが安定的に製造で
きる等の利点からマウスモノクローナル抗体が広く用い
られるようになり、マウスモノクローナル抗体を用いた
酵素標識抗体の重要性が増加している。[0008] Conventionally, polyclonal antibodies such as rabbit and goat antibodies have been widely used. However, in recent years, mouse monoclonal antibodies have become widely used due to their high specificity and the ability to stably produce products of constant quality, and the importance of enzyme-labeled antibodies using mouse monoclonal antibodies has increased. There is.
【0009】[0009]
【発明が解決しようとする課題】マウスモノクローナル
抗体IgG画分にはIgG1、IgG2a、IgG2b
、IgG3のサブクラスがある。これらのうちIgG1
およびIgG3のサブクラス抗体については、容易にペ
プシン消化によりF(ab’)2とし、更に還元するこ
とによりスルフヒドリル基を遊離させ、酵素と結合させ
て酵素標識抗体を得ることができる。Problems to be Solved by the Invention: Mouse monoclonal antibody IgG fractions contain IgG1, IgG2a, and IgG2b.
, IgG3 subclass. Among these, IgG1
and IgG3 subclass antibodies can be easily converted to F(ab')2 by pepsin digestion, further reduced to release the sulfhydryl group, and combined with an enzyme to obtain an enzyme-labeled antibody.
【0010】しかしIgG2a及びIgG2bのサブク
ラス抗体は、ペプシン消化をすると低分子のペプチドま
で分解が進み、抗体活性を有するF(ab’)2画分が
得られないことが分かっている。従って一般に、測定し
ようとする抗原に対するモノクローナル抗体として、I
gG1またはIgG3のサブクラスの抗体を選択して使
用してきた。しかし特異性や反応性の高い酵素免疫測定
法に適したマウスモノクローナル抗体を得ることは容易
ではなく、結果的にIgG2aまたはIgG2bしか入
手できなかった場合、やむを得ず抗体のアミノ基を利用
した方法で酵素標識抗体を調製し、感度の悪い測定に甘
んじてきた。[0010] However, it is known that when subclass antibodies of IgG2a and IgG2b are digested with pepsin, decomposition progresses to low-molecular-weight peptides, making it impossible to obtain an F(ab')2 fraction having antibody activity. Therefore, in general, as a monoclonal antibody against the antigen to be measured, I
Antibodies of the gG1 or IgG3 subclass have been selected and used. However, it is not easy to obtain mouse monoclonal antibodies suitable for enzyme-linked immunosorbent assays that have high specificity and reactivity, and when only IgG2a or IgG2b were available, it was unavoidable to use a method that utilizes the amino groups of antibodies to obtain enzyme-linked antibodies. We have prepared labeled antibodies and have been content with measurements with poor sensitivity.
【0011】[0011]
【問題を解決するための手段】本発明は、マウスモノク
ローナル抗体IgG2a及びIgG2bサブクラスのス
ルフヒドリル基を介して酵素と結合された酵素標識抗体
を提供するものであり、本発明によりマウスモノクロー
ナル抗体のIgG2a及びIgG2bサブクラスが高感
度酵素免疫測定法に利用可能になった。[Means for Solving the Problems] The present invention provides an enzyme-labeled antibody that is linked to an enzyme through the sulfhydryl group of the mouse monoclonal antibody IgG2a and IgG2b subclasses. The IgG2b subclass has become available for highly sensitive enzyme-linked immunosorbent assays.
【0012】すなわちこれらサブクラスの抗体をペプシ
ンで消化することなく、還元剤で処理し、スルフヒドリ
ル基の遊離した半分子の抗体を得る。抗体の還元処理と
並行して、二価性結合試薬を用いてマレイミド基を導入
した酵素を調製する。次にスルフヒドリル基の遊離した
半分子の抗体とマレイミド基の導入された酵素を混合し
、反応させる。反応終了後ゲル濾過により精製し、目的
の酵素標識抗体を得ることができる。That is, antibodies of these subclasses are treated with a reducing agent without being digested with pepsin to obtain half-molecule antibodies with free sulfhydryl groups. In parallel with the antibody reduction treatment, a maleimide group-introduced enzyme is prepared using a bivalent binding reagent. Next, half of the antibody with a free sulfhydryl group and an enzyme with a maleimide group introduced are mixed and allowed to react. After the reaction is completed, the target enzyme-labeled antibody can be obtained by purification by gel filtration.
【0013】抗体の還元には2−メルカプトエチルアミ
ン、2−メルカプトエタノール、ジチオスレイトール等
の還元作用を持つ試薬を利用できる。pH5.0〜7.
0の範囲の0.1M酢酸緩衝液やりん酸緩衝液中に抗体
を溶解し、5から20mMの範囲で還元剤を添加する。
25〜37℃で30〜90分間保温し、還元する。条件
は使用する還元剤や抗体クローンの性質等で多少異なる
ので、予備実験で至適条件を設定する必要がある。[0013] For reducing the antibody, reagents having a reducing action such as 2-mercaptoethylamine, 2-mercaptoethanol, dithiothreitol, etc. can be used. pH5.0-7.
The antibody is dissolved in 0.1M acetate buffer or phosphate buffer in the range of 0.0 to 0.0, and a reducing agent is added in the range of 5 to 20mM. Incubate at 25-37°C for 30-90 minutes to reduce. Since the conditions differ somewhat depending on the reducing agent used, the properties of the antibody clone, etc., it is necessary to set the optimal conditions through preliminary experiments.
【0014】マレイミド基導入酵素は、酵素のアミノ基
にアミノ基及びスルフヒドリル基と結合する二価性結合
試薬を反応させることにより調製することができる。具
体的には、前述したN−succinimidyl−6
−maleimidohexanoate、N−suc
cinimidyl−4−(N−maleimidom
ethyl)−cyclohexane−1−carb
oxylateやその誘導体であるN−sulfosu
ccinimidyl−4−(N−maleimido
methyl)−cyclohexane−1−car
boxylate等をN,N−dimethylfor
mamideに溶解し(10〜100mM)、10倍容
量の酵素溶液(0.5〜10mg/0.1Mりん酸緩衝
液、pH7.0)に添加して、25〜37℃、20〜9
0分反応させ、ゲルろ過により未反応の結合試薬を除い
て得る。A maleimide group-introducing enzyme can be prepared by reacting an amino group of the enzyme with a divalent binding reagent that binds to an amino group and a sulfhydryl group. Specifically, the aforementioned N-succinimidyl-6
-maleimidohexanoate, N-suc
cinimidyl-4-(N-maleimidom
ethyl)-cyclohexane-1-carb
oxylate and its derivative N-sulfosu
ccinimidyl-4-(N-maleimido
methyl)-cyclohexane-1-car
N,N-dimethylfor boxylate etc.
mamide (10-100mM) and added to 10 times the volume of enzyme solution (0.5-10mg/0.1M phosphate buffer, pH 7.0) at 25-37℃, 20-9
After 0 minutes of reaction, unreacted binding reagents are removed by gel filtration.
【0015】この場合の酵素としては、西洋ワサビペル
オキシダーゼ、グルコースオキシダーゼ、アルカリフォ
スファターゼ、β−ガラクトシターゼ等一般的に酵素免
疫測定法に用いられている多くの酵素が利用できる。ま
た大腸由来のβ−ガラクトシダーゼには遊離のスルフヒ
ドリル基が存在しており、このスルフヒドリル基に二価
性結合試薬であるN,N’−o−phenylened
imaleimideを反応させることにより、マレイ
ミド基導入β−ガラクトシダーゼを得ることができる。[0015] As the enzyme in this case, many enzymes commonly used in enzyme immunoassay methods can be used, such as horseradish peroxidase, glucose oxidase, alkaline phosphatase, and β-galactosidase. In addition, β-galactosidase derived from the large intestine has a free sulfhydryl group, and this sulfhydryl group is bound to N,N'-o-phenylened, which is a divalent binding reagent.
By reacting with imalimide, maleimide group-introduced β-galactosidase can be obtained.
【0016】このようにして得たスルフヒドリル基の遊
離した半分子の抗体とマレイミド基の導入された酵素を
りん酸緩衝液、pH6.0〜7.0中で混合し、4〜3
7℃、1〜24時間反応させる。反応後、ゲルろ過クロ
マトにより精製して酵素標識抗体を得る。[0016] The antibody with the free half of the sulfhydryl group thus obtained and the enzyme into which the maleimide group has been introduced are mixed in a phosphate buffer solution, pH 6.0 to 7.0, and
React at 7°C for 1 to 24 hours. After the reaction, the enzyme-labeled antibody is obtained by purification by gel filtration chromatography.
【0017】[0017]
【実施例】以下に、本発明に係わる酵素標識抗体の調製
、またこれを用いた酵素免疫測定などの実施例及び参考
例について述べるが、これらは本発明を更に詳細に説明
する為のものであり、本発明はこれらの実施例に限定さ
れるものではない。[Example] Examples and reference examples such as the preparation of enzyme-labeled antibodies according to the present invention and enzyme immunoassay using the same will be described below, but these are not intended to explain the present invention in more detail. However, the present invention is not limited to these examples.
【0018】[0018]
【実施例1 マウスモノクローナル抗体、IgG2a
サブクラスを用いた酵素標識抗体の調製】0.05Mり
ん酸緩衝液、pH6.5、0.1M NaCl含有、
に溶解した抗ミオシンマウスモノクローナル抗体IgG
2aサブクラス(クローン番号M705、1mg/0.
2ml)に0.5M 2−メルカプトエチルアミンを
5μl添加し、37℃、90分加温したのち、0.1M
りん酸緩衝液、pH6.0で平衡化されたセファデック
スG−25カラムに通して還元抗体を得た。一方これと
並行して0.1Mりん酸緩衝液、pH7.0に溶解した
西洋ワサビペルオキシダーゼ(2mg/0.3ml)に
N,N−dimethylformamideに溶解し
た50mMのN−succimidyl−4−(N−m
aleimidomethyl)−cyclohexa
ne−1−carboxylateを加え、30℃、1
時間反応させた。反応後同様にG−25カラムに通しマ
レイミド基の導入された酵素を得た。これらの還元抗体
及びマレイミド酵素を混合し、4℃、24時間放置した
後、0.1Mりん酸緩衝液、pH6.5で平衡化したT
SKゲル、G3000SW(東ソー)に通しゲル濾過に
よる精製を行い、西洋ワサビペルオキシダーゼ標識マウ
スモノクローナル抗体をIgG2aサブクラスを得た。[Example 1 Mouse monoclonal antibody, IgG2a
Preparation of enzyme-labeled antibodies using subclasses] 0.05M phosphate buffer, pH 6.5, containing 0.1M NaCl;
Anti-myosin mouse monoclonal antibody IgG dissolved in
2a subclass (clone number M705, 1 mg/0.
2 ml) was added with 5 μl of 0.5M 2-mercaptoethylamine, heated at 37°C for 90 minutes, and then 0.1M
Reduced antibodies were obtained by passing through a Sephadex G-25 column equilibrated with phosphate buffer, pH 6.0. Meanwhile, in parallel, horseradish peroxidase (2 mg/0.3 ml) dissolved in 0.1 M phosphate buffer, pH 7.0, and 50 mM N-succimidyl-4-(N- m
aleimidomethyl)-cyclohexa
Add ne-1-carboxylate and incubate at 30°C for 1
Allowed time to react. After the reaction, the enzyme was passed through a G-25 column in the same manner to obtain an enzyme into which a maleimide group had been introduced. These reduced antibodies and maleimide enzyme were mixed and left at 4°C for 24 hours, then T
Purification was performed by gel filtration through SK gel and G3000SW (Tosoh) to obtain a horseradish peroxidase-labeled mouse monoclonal antibody of the IgG2a subclass.
【0019】[0019]
【実施例2 マウスモノクローナル抗体、IgG2b
サブクラスを用いた酵素標識抗体の調製】実施例1で用
いたモノクローナル抗体の代わりに、異なった融合細胞
株の産生する抗ミオシンマウスモノクローナル抗体、I
gG2bサブクラス抗体(クローン番号M904)を実
施例1と同様の操作で酵素標識し、西洋ワサビペルオキ
シダーゼ標識マウスモノクローナル抗体をIgG2bサ
ブクラスを得た。[Example 2 Mouse monoclonal antibody, IgG2b
Preparation of enzyme-labeled antibodies using subclasses] Instead of the monoclonal antibodies used in Example 1, anti-myosin mouse monoclonal antibodies produced by different fusion cell lines, I
A gG2b subclass antibody (clone number M904) was enzyme-labeled in the same manner as in Example 1 to obtain a horseradish peroxidase-labeled mouse monoclonal antibody of the IgG2b subclass.
【0020】[0020]
【参考例1 過ヨウ素酸酸化法による酵素標識抗体の
調製】西洋ワサビペルオキシダーゼ水溶液(4mg/m
l)0.5mlに0.2Mメタ過ヨウ素酸ナトリウム水
溶液、300μlを加え、室温20分放置した。その後
、1mM酢酸緩衝液、pH4.5に対し透析した。透析
内液に0.2M重炭酸ナトリウム緩衝液、pH9.5を
加え、pHを9に調整した後、抗ミオシンマウスモノク
ローナル抗体(クローン番号M705又は904)溶液
(4mg/0.5ml)を加え、室温2時間放置し反応
させた。反応後、60μlの水素化ホウ素ナトリウム水
溶液(4mg/ml)を加え、還元処理した後、G30
00SWカラムに通し精製して、ペルオキシダーゼ標識
抗体を得た。[Reference Example 1 Preparation of enzyme-labeled antibody by periodate oxidation method] Horseradish peroxidase aqueous solution (4 mg/m
l) 300 μl of 0.2 M sodium metaperiodate aqueous solution was added to 0.5 ml and left at room temperature for 20 minutes. Thereafter, it was dialyzed against 1mM acetate buffer, pH 4.5. After adding 0.2M sodium bicarbonate buffer, pH 9.5 to the dialysate solution and adjusting the pH to 9, anti-myosin mouse monoclonal antibody (clone number M705 or 904) solution (4 mg/0.5 ml) was added. The mixture was left to react at room temperature for 2 hours. After the reaction, 60 μl of sodium borohydride aqueous solution (4 mg/ml) was added, and after reduction treatment, G30
The peroxidase-labeled antibody was obtained by purification through a 00SW column.
【0021】[0021]
【実施例3 酵素免疫測定法によるミオシン軽鎖の測
定】抗ミオシンマウスモノクローナル抗体IgMサブク
ラス(クローン番号M510)を不溶化したマイクロプ
レートに50μlの標準ミオシン溶液及び0.1Mりん
酸緩衝液(pH6.5、0.15M NaCl、0.
5%牛血清アルブミン含有)で希釈調整した酵素標識抗
体を加え、室温1時間反応させた。反応後プレートを0
.1%Tween−20を含有するトリス−塩酸緩衝生
理食塩水で4回洗浄し、2,2’−アミノ−ビス−3−
エチルベンゾチアゾリン−6−スルホン酸と過酸化水素
からなる発色性酵素基質液100μlを加え、室温5分
反応させた。100μlの1%蓚酸を加え、反応を停止
させた後、414nmにおける吸光度を測定し、検量線
を作成した。結果を表1に示す。[Example 3 Measurement of myosin light chain by enzyme immunoassay] 50 μl of standard myosin solution and 0.1 M phosphate buffer (pH 6.5 , 0.15M NaCl, 0.
An enzyme-labeled antibody diluted with 5% bovine serum albumin (containing 5% bovine serum albumin) was added and allowed to react at room temperature for 1 hour. After reaction, zero the plate.
.. Washed 4 times with Tris-HCl buffered saline containing 1% Tween-20, 2,2'-amino-bis-3-
100 μl of a chromogenic enzyme substrate solution consisting of ethylbenzothiazoline-6-sulfonic acid and hydrogen peroxide was added, and the mixture was allowed to react at room temperature for 5 minutes. After adding 100 μl of 1% oxalic acid to stop the reaction, the absorbance at 414 nm was measured and a calibration curve was created. The results are shown in Table 1.
【0022】[0022]
【表1】[Table 1]
【0023】表1に示したように、本発明による実施例
及び実施例2で得た酵素標識抗体を用いて得た検量線は
何れもブランクが低いにもかかわらず、急峻なカーブと
なり、高感度且つ高精度の測定が可能であった。一方参
考例で得た酵素標識抗体による済量線は、ブランクが高
くまた傾きの小さいカーブとなり、酵素免疫測定法には
適さないものであった。As shown in Table 1, the calibration curves obtained using the enzyme-labeled antibodies obtained in Examples according to the present invention and Example 2 were both steep curves despite the fact that the blank was low. Sensitive and highly accurate measurements were possible. On the other hand, the calibration curve obtained using the enzyme-labeled antibody obtained in the reference example had a high blank and a curve with a small slope, and was not suitable for enzyme immunoassay.
【0024】[0024]
【発明の効果】以上説明したように、本発明によりマウ
スモノクローナル抗体のIgG2a及びIgG2bサブ
クラス抗体を用いた。高感度酵素免疫測定法に適した酵
素標識抗体が利用可能となった。この様にマウスモノク
ローナル抗体のIgG2a及びIgG2bサブクラス抗
体の、免疫測定の分野における利用価値を高めた意義は
極めて大きい。Effects of the Invention As explained above, according to the present invention, IgG2a and IgG2b subclass antibodies of mouse monoclonal antibodies were used. Enzyme-labeled antibodies suitable for highly sensitive enzyme-linked immunosorbent assays are now available. Thus, the significance of increasing the utility value of IgG2a and IgG2b subclass antibodies of mouse monoclonal antibodies in the field of immunoassay is extremely significant.
【表1】
A414、2重測定平
均値 酵素標識抗体 標準ミ
オシン濃度 (ng/ml)
0
12.5 25 50
100 実施例1
0.003 0.285 0.546
0.905 1.295 実施例2
0.002 0.19
8 0.368 0.579 0.
881 参考例1[Table 1]
A414, average value of duplicate measurements Enzyme-labeled antibody standard myosin concentration (ng/ml)
0
12.5 25 50
100 Example 1
0.003 0.285 0.546
0.905 1.295 Example 2
0.002 0.19
8 0.368 0.579 0.
881 Reference example 1
Claims (2)
抗体において、抗体を還元しスルフヒドリル基を遊離さ
せ、このスルフヒドリル基を利用して酵素を結合させて
得ることを特徴とする酵素標識抗体。1. An enzyme-labeled antibody obtained by binding an enzyme to an antibody, which is obtained by reducing the antibody to liberate a sulfhydryl group, and then binding an enzyme using the sulfhydryl group.
ル抗体IgG画分のサブクラスのうち、IgG2aまた
はIgG2bであることを特徴とする酵素標識抗体。2. An enzyme-labeled antibody characterized in that the antibody according to claim 1 is an IgG2a or IgG2b subclass of the IgG fraction of a mouse monoclonal antibody.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8065591A JPH04291155A (en) | 1991-03-20 | 1991-03-20 | Enzyme labeled antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8065591A JPH04291155A (en) | 1991-03-20 | 1991-03-20 | Enzyme labeled antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04291155A true JPH04291155A (en) | 1992-10-15 |
Family
ID=13724375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8065591A Pending JPH04291155A (en) | 1991-03-20 | 1991-03-20 | Enzyme labeled antibody |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04291155A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605791A (en) * | 1992-08-05 | 1997-02-25 | Genentech, Inc. | Carbohydrate-directed cross-linking reagents |
-
1991
- 1991-03-20 JP JP8065591A patent/JPH04291155A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605791A (en) * | 1992-08-05 | 1997-02-25 | Genentech, Inc. | Carbohydrate-directed cross-linking reagents |
US5889155A (en) * | 1992-08-05 | 1999-03-30 | Genentech, Inc. | Carbohydrate-directed cross-linking reagents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1120398A (en) | Coupling reagent of immuno-active molecule to an enzyme | |
JPH02231467A (en) | Composition and method for quantitatively determining existence of anphetamines | |
WO1992010507A1 (en) | Site-specific conjugation of immunoglobulins and detectable labels | |
KR100249752B1 (en) | Interference-suppressing reagent specific to certain classes of antibodies | |
JPH01114758A (en) | Manufacture of antibody fragment preparation containing no papain | |
JPH0579943B2 (en) | ||
JPS60155134A (en) | Monoclonal antibody against alpha-amylase of saliva and method and reagent for measuring alpha-amylase of pancreas as well as of humoral saliva | |
JPH04291155A (en) | Enzyme labeled antibody | |
JP4183777B2 (en) | Indoxyl sulfate derivative, antigen, antibody and method for detecting indoxyl sulfate using the same | |
JP2000502792A (en) | Method for labeling biomolecules using horseradish peroxidase | |
WO1997016727A1 (en) | Assay background reduction using glycoproteins with oxidized carbohydrates | |
JP2968910B2 (en) | Antibodies against 1α, 25 (OH) 2 vitamin D3 and uses thereof | |
JP4071330B2 (en) | Anti-human medalacin monoclonal antibody, production method thereof and immunological assay method using the same | |
JPS6113156A (en) | Reagent for quantitative analysis of human interferon-alpha and determination method thereof | |
JPS58149700A (en) | Composite containing peroxidase, its preparation and reagent | |
JPH0534353A (en) | Immunological method for determination of human 92kda gelatinase | |
JPH07313186A (en) | Anti-pivka-ii monoclonal antibody | |
JPS59210366A (en) | Manufacture of insolubilized antigen and insolubilized antibody for immunological assay | |
US4942136A (en) | Method for production of fluorescence-labeled Fab' | |
JPS63209596A (en) | Monoclonal antibody and use thereof | |
SU1573427A1 (en) | Method of determining theophylline in blood serum | |
JPH0792456B2 (en) | Enzymatically labeled catecholamine acid metabolite | |
JP2520465B2 (en) | Multi-labeled antibody | |
JPS62245964A (en) | Reagent for measuring c3a by immunochemical assay and measurement method | |
JPH058678B2 (en) |